Bernstein Bruce — SEC insider filings
SEC reporting owner CIK 1665472. 66 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers the 50 most recent of 66 filings on record, filed 2022-06-23 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 50,000 shares, $21,097 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 22,500 shares, $26,368 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 60.
- Largest priced transaction: sale of 22,500 shares @ $1.17 ($26,368) in TAO Synergies Inc., filed 2022-12-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TAO Synergies Inc. (TAOX) | Director | 12 | — | 1 leg · 22,500 sh · $26,368 | 15 |
| XWELL, Inc. (XWEL) | Director | 7 | 2 legs · 50,000 sh · $21,097 | — | 7 |
| WRAP TECHNOLOGIES, INC. (WRAP) | Director | 21 | — | — | 24 |
| Petros Pharmaceuticals, Inc. (PTPI) | Director | 7 | — | — | 9 |
| RRE Ventures Acquisition Corp. (RREV) | Director | 1 | — | — | 3 |
| Q/C TECHNOLOGIES, INC. (QCLS) | Director | 2 | — | — | 2 |
Insider filings — Bernstein Bruce
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-10-09 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 21,154 @ $0 | EDGAR |
| 2026-09-02 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 500,000 @ $0 | EDGAR |
| 2026-07-06 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 34,998 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 1,875,000 @ $0 | EDGAR |
| 2026-05-19 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | RRE Ventures Acquisition Corp. (RREV) | Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $1 | EDGAR |
| 2026-05-01 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 19,643 @ $0 | EDGAR |
| 2026-04-15 | 4 | Q/C TECHNOLOGIES, INC. (QCLS) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2026-02-03 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 10,409 @ $0 | EDGAR |
| 2026-01-05 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 12,710 @ $0 | EDGAR |
| 2026-01-02 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 1,875,000 @ $0 | EDGAR |
| 2025-11-14 | 4 | Q/C TECHNOLOGIES, INC. (QCLS) | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2025-10-17 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 25,000 @ $0 · Tax withholding (F): 10,000 @ $7.23 · Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 13,940 @ $0 | EDGAR |
| 2025-07-10 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 19,391 @ $0 | EDGAR |
| 2025-07-02 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 24,657 @ $0 · Tax withholding (F): 9,863 @ $7.85 | EDGAR |
| 2025-06-03 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 200,926 · Grant/award (A): 220,528 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 19,643 @ $0 | EDGAR |
| 2025-04-07 | 4 | Synaptogenix, Inc. (SNPX) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-02-13 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 5,051 @ $0 · Grant/award (A): 9,091 @ $0 | EDGAR |
| 2025-01-06 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 14,269 @ $0 | EDGAR |
| 2024-11-18 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 44,037 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 20,167 @ $0 | EDGAR |
| 2024-07-03 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 15,125 @ $0 | EDGAR |
| 2024-04-10 | 4 | Synaptogenix, Inc. (SNPX) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 13,385 @ $0 | EDGAR |
| 2024-01-18 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 9,758 @ $0 | EDGAR |
| 2024-01-18 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 4,786 @ $0 | EDGAR |
| 2024-01-09 | 4/A | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-08 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-12-26 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-10-19 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 10,083 | EDGAR |
| 2023-07-10 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 8,083 | EDGAR |
| 2023-04-28 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Option exercise (M): 6,050 · Option exercise (M): 6,050 (derivative) @ $0 | EDGAR |
| 2023-04-26 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 30,000 (derivative) | EDGAR |
| 2023-04-12 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2023-03-31 | 4 | Synaptogenix, Inc. (SNPX) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-01-25 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Option exercise (M): 2,264 · Option exercise (M): 2,264 (derivative) @ $0 | EDGAR |
| 2023-01-09 | 4/A | XWELL, Inc. (XWEL) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2023-01-09 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2022-12-20 | 4 | Synaptogenix, Inc. (SNPX) | Sale (S): 22,500 @ $1.17 | EDGAR |
| 2022-12-01 | 4 | XWELL, Inc. (XWEL) | Purchase (P): 16,110 @ $0.41 · Purchase (P): 33,890 @ $0.43 | EDGAR |
| 2022-12-01 | 4/A | Synaptogenix, Inc. (SNPX) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Synaptogenix, Inc. (SNPX) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-06-23 | 4/A | Synaptogenix, Inc. (SNPX) | Other (J): 0 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1665472 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs